Portomesenteric Vein Thrombosis After Metabolic and Bariatric Surgery: Incidence, Predictors, and Timing
Surgery for Obesity and Related Diseases · 2026-10
DOI: 10.1016/j.soard.2026.10.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgery for Obesity and Related Diseases, 2026-10. Verfasst von Hector J. Garcia Navas und 9 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Portomesenteric Vein Thrombosis (PVT) is a rare but potentially devastating complication following metabolic and bariatric surgery (MBS). Risk factors and chemoprophylactic strategies remain poorly defined given its low incidence.
Objective
Assess the incidence, timing, and risk factors of PVT following MBS.
Setting
TriNetX, a global federated health research network, 2010-2024 Methods Adults (≥ 18 years) with BMI ≥ 30 kg/m 2 and documented race/ethnicity who underwent sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) were identified. Primary outcomes included incidence of PVT, deep vein thrombosis (DVT), and pulmonary embolus (PE) within 12 months postoperatively. A sensitivity analysis assessed time to PVT within 8 postoperative weeks. Demographic and clinical characteristics were summarized descriptively. Regression models were used to assess risk factors and Kaplan-Meier methods estimated cumulative incidence and generated a time-to-event curve.
Results
Among 88,689 MBS cases (64% SG; 36% RYGB), 184 developed PVT, 863 developed DVT, and 850 developed PE. SG, Black race, liver fibrosis/cirrhosis, and prior venous thromboembolism (VTE) were associated with increased risk of PVT at both 8 weeks and 12 months postoperatively. Among PVTs following SG, 82% occurred within 8 weeks; however, 29% were not diagnosed until after 4 weeks postoperatively.
Conclusion
PVT remains a rare but important potential complication of MBS. In the largest cohort to date, this study confirms greater risk of PVT with SG and identifies Black race, liver fibrosis/cirrhosis, and prior VTE as predictors. Given that nearly one-third of PVTs occurred beyond 4 weeks, clinical vigilance should extend beyond this period. Prospective studies are needed to investigate whether extended chemoprophylaxis beyond this time reduces PVT incidence.
Zitieren
APA
Navas, H. J. G., Bhatia, S., Dahlgren, N., Kachmar, M., Teklu, Y., Galvani, C., Danos, D. M., Schauer, P. R., Albaugh, V. L., & Cook, M. W. (2026). Portomesenteric Vein Thrombosis After Metabolic and Bariatric Surgery: Incidence, Predictors, and Timing. Surgery for Obesity and Related Diseases. https://doi.org/10.1016/j.soard.2026.10.010
Vancouver
Navas HJG, Bhatia S, Dahlgren N, Kachmar M, Teklu Y, Galvani C, et al. Portomesenteric Vein Thrombosis After Metabolic and Bariatric Surgery: Incidence, Predictors, and Timing. Surgery for Obesity and Related Diseases. 2026. doi:10.1016/j.soard.2026.10.010
BibTeX
@article{Navas2026,
author = {Navas, Hector J. Garcia and Bhatia, Shubham and Dahlgren, Nicholas and Kachmar, Michael and Teklu, Yonas and Galvani, Carlos and Danos, Denise M. and Schauer, Philip R. and Albaugh, Vance L. and Cook, Michael W.},
title = {Portomesenteric Vein Thrombosis After Metabolic and Bariatric Surgery: Incidence, Predictors, and Timing},
journal = {Surgery for Obesity and Related Diseases},
year = {2026},
doi = {10.1016/j.soard.2026.10.010}
}
EUVIMED